



- Stock: In Stock
- Model: 179211
0% Customers recommend this product
-
5 Awesome0%
-
4 Great0%
-
3 Average0%
-
2 Bad0%
-
1 Poor0%
Reviews Over Nicotinic K-ta-Zdorovye solution for infection. 10mg/ml amp. 1 ml No. 10
- (0)
Total Reviews (0)
click here write review to add review for this product.
Report this review.
Description
Solution "Nicotinic kislota-Zdorovye" is applied to injections at the following indications:
- treatment of a pellagra (PP vitamin avitaminosis);
- ischemic violations of cerebral circulation;
- angiospasm of extremities (obliterating endarteritis, Raynaud's disease);
- angiospasm of kidneys;
- a wound, an ulcer which do not begin to live a long time;
- a complication of diabetes (diabetic polyneuropathy, mikroangiopatiya);
- gipoatsidny gastritis, coloenteritis, colitis;
- a disease of a liver (acute and chronic hepatitises);
- neuritis of a facial nerve;
- intoxication of various genesis: professional, alcoholic, medicamentous (aniline derivatives, barbiturates, antituberculous remedies, streptocides).
Structure
1 ml of solution contains (active ingredient) of niacin of 10 mg.
Excipients: Natrii hydrocarbonas, water for injections.
Contraindication
- hypersensitivity to medicine components;
- a peptic ulcer of a stomach and duodenum (in an aggravation stage), gout, a hyperuricemia, a heavy liver failure (including cirrhosis), severe forms of arterial hypertension and atherosclerosis (intravenous administration), dekompensirovanny diabetes, a recent myocardial infarction, sudden decrease in peripheric vascular resistance in the anamnesis.
by
to adults and children is more senior than 15 years intravenously (slowly), intramusculary and subcutaneously (intramuscular and subcutaneous injections are painful).
a single dose of medicine to dissolve withFor jet introduction to 10 ml 0.9% of solution of sodium of chloride; to enter not less than in 5 minutes (no more than 2 mg of niacin in one minute). For intravenous drop administration a single dose of medicine to dissolve in 100-200 ml 0.9% of solution of sodium of chloride, rate of administering - 30-40 drops one minute.
Pellagra. To appoint intravenously or intramusculary 10 mg (1 ml) 1-2 times a day. A course of treatment - 10-15 days.
Ischemic violations of cerebral circulation. Intravenously (slowly) to enter 10 mg (1 ml).
Other indications. To appoint subcutaneously or intramusculary 10 mg (1 ml) once a day within 10-15 days. Addition in infusion solution of 10 mg (1 ml) of niacin on 100-200 ml of solution is possible.
Highest doses at intravenous administration: single - 100 mg (10 ml), daily - 300 mg (30 ml).
toPregnant
toDrug is contraindicated to
Feature of application
during pregnancy. In need of use of medicine it is necessary to stop feeding by a breast.Children
Drug to children to appoint more senior than 15 years.
DriversResearches about influence of medicine on speed of response were not conducted by
, however, if during treatment the dizziness and drowsiness are observed, it is necessary to abstain from work with difficult mechanisms. Overdose
Symptoms: strengthening of side effects from a cardiovascular system: arterial hypotension, a headache, is possible a loss of consciousness, dizziness, feeling of inflows.
Treatment: medicament withdrawal, disintoxication therapy, symptomatic treatment. Specific antidote is absent.
Side effects
from a cardiovascular system: feeling of inflows which can be followed by an asthma, tachycardia, heartbeat, sweating, a fever, hypostases, feeling of pricking and burning; at fast intravenous administration - a considerable lowering of arterial pressure, orthostatic hypotension, collapse.
from nervous system: headache, dizziness, paresthesias.
Local reactions: morbidity in the place of subcutaneous and intramuscular injections.
Other allergic reactions (in the ohm rash number exhausting naggers, a small tortoiseshell), dryness of skin and mucous membrane of eyes; seldom - hypostasis of a retina of eyes; very seldom at patients with coronary heart disease - arrhythmias, an acanthosis (brown spots on skin a velvety surface). These symptoms are unstable and disappear after medicament withdrawal.
At prolonged use in high doses: a hyperpegmentation, spasms, diarrhea, nausea, vomiting, anorexia, exacerbation of stomach ulcer, an amblyopia, jaundice, a hyperuricemia, fat dystrophy of a liver, increase in level of glucose (decrease in tolerance), uric acid, aspartate aminotransferase, a lactate dehydrogenase and alkaline phosphatase in blood, a hypophosphatemia, decrease in quantity of platelets, increase in a prothrombin time, insomnia, myalgia, a lowering of arterial pressure, rhinitis, misting of sight, the century, a myopathy, exfoliative dermatitis swelled.
Interaction
should not be mixed with Thiamini chloridum solutions (there are thiamine destructions), a pyridoxine of a hydrochloride, cyanocobalamin, Euphyllinum, salicylates, tetracycline, sympathomimetics, a hydrocortisone.
Storage conditionsto Store
in original packing at a temperature not above 25 °C, out of children's reach.
Expiration date - 5 years.
Specifications
Characteristics | |
Active ingredients | Niacin |
Amount of active ingredient | 10 mg/ml |
Applicant | Health |
Code of automatic telephone exchange | C04AC01 niacin |
Interaction with food | It doesn't matter |
Light sensitivity | Not sensitive |
Market status | Traditional |
Origin | Chemical |
Prescription status | According to the prescription |
Primary packing | ampoule |
Producer | TOB PHARMACEUTICAL COMPANY HEALTH |
Quantity in packing | 10 ampoules on 1 ml |
Release form | solution for injections |
Route of administration | Intramuscular |
Sign | Domestic |
Storage temperature | from 5 °C to 25 °C |
Trade name | Niacin |